Fidelity Funds Q2 2024 Review: Overseas and Multi-Asset Income Performance

Fidelity Overseas Fund Performance

The Fidelity Overseas Fund demonstrated a robust performance in Q2 2024, with a notable return of 3.70% 1

1

. This performance outpaced its benchmark, the MSCI EAFE Index, which returned 3.23% during the same period. The fund's success can be attributed to its strategic stock selection and sector allocation, particularly in the information technology and healthcare sectors.

Key Contributors to Overseas Fund

Significant contributors to the fund's performance included ASML Holding, a Dutch semiconductor equipment manufacturer, and Novo Nordisk, a Danish pharmaceutical company 1

1

. These stocks benefited from the growing demand for advanced chip manufacturing and diabetes treatments, respectively. The fund's overweight position in these companies proved advantageous in the current market environment.

Fidelity Multi-Asset Income Fund Overview

The Fidelity Multi-Asset Income Fund, designed to provide a steady income stream and potential capital appreciation, delivered a solid performance in Q2 2024 2

2

. The fund's diversified approach across various asset classes, including stocks, bonds, and alternative investments, helped mitigate risks while capitalizing on market opportunities.

Multi-Asset Income Fund Performance

For the quarter, the Multi-Asset Income Fund returned 2.85%, slightly underperforming its custom benchmark, which returned 3.01% 2

2

. Despite this marginal underperformance, the fund maintained its focus on generating consistent income for investors while managing overall portfolio risk.

Asset Allocation Strategy

The fund's asset allocation strategy played a crucial role in its performance. As of Q2 2024, the portfolio comprised approximately 45% stocks, 40% bonds, and 15% alternative investments 2

2

. This balanced approach allowed the fund to benefit from equity market gains while providing stability through fixed-income holdings.

Market Factors Influencing Performance

Both funds were influenced by broader market trends during Q2 2024. Global economic recovery, inflation concerns, and central bank policies were key factors affecting investment performance. The technology sector's continued strength and the healthcare sector's resilience in the face of ongoing global health challenges contributed positively to both funds' returns.

Outlook and Future Positioning

Looking ahead, Fidelity fund managers remain cautiously optimistic about global market prospects. For the Overseas Fund, the focus will continue to be on identifying high-quality companies with strong growth potential in international markets 1

1

. The Multi-Asset Income Fund is expected to maintain its diversified approach, potentially adjusting allocations to optimize income generation and capital preservation in response to changing market conditions 2

2

.

Investor Considerations

Investors should note that while both funds have shown positive performance, past results do not guarantee future returns. The Overseas Fund may be suitable for those seeking international exposure and growth potential, while the Multi-Asset Income Fund could appeal to investors prioritizing income generation and risk management. As always, individual investment decisions should be made based on personal financial goals and risk tolerance.